Trial Profile
A trial to study the effect of eribulin in management of advanced breast cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 07 Jun 2016 New trial record